Clinical and laboratory features of B-ALL patients
| Patient no. . | Sex . | Age, y . | Immunologic subtype . | Genetic translocation . |
|---|---|---|---|---|
| 1 | F | 7 | Early-pre | 9;22/4;11 neg* |
| 2 | F | 6 | Early-pre | 9;22/4;11 neg |
| 3 | F | 5 | Early-pre | 9;22/4;11 neg |
| 4 | F | 4 | Early-pre | 9;22/4;11 neg |
| 5 | M | 3 | Early-pre | 9;22/4;11 neg |
| 6 | M | 2 | Early-pre | 9;22/4;11 neg |
| 7 | F | 8 | Early-pre | 12;21 |
| 8 | F | 7 | Early-pre | 12;21 |
| 9 | M | 6 | Early-pre | 12;21 |
| 10 | M | 5 | Early-pre | Neg† |
| 11 | M | 3 | Early-pre | 12;21 |
| 12 | M | 2 | Early-pre | 9;22 and 1;19 |
| 13 | M | 6 | Early-pre | 12;21 |
| 14 | M | 2 | Early-pre | Neg |
| 15 | M | 8 | Early-pre | Neg |
| 16 | M | 5 | Early-pre | Neg |
| 17 | M | 4 | Early-pre | Neg |
| 18 | M | 12 | Early-pre | Neg |
| 19 | F | 6 | Early-pre | Neg |
| 20 | M | 6 | Pre-B | 12;21 |
| 21 | M | 3 | Pre-B | Neg |
| 22 | M | 2 | Pre-B | Down syndrome |
| 23 | F | 8 | Pre-B | 1;19 |
| 24 | F | 8 | Pre-B | Neg |
| 25 | M | 6 | Pre-B | Neg |
| 26 | F | < 1 (infant) | Pro-B | 4;11 |
| 27 | F | 3 | Pro-B | Neg |
| 28 | F | 5 | Pro-B | Neg |
| 29 | M | 4 | Pro-B | 4;11 |
| Patient no. . | Sex . | Age, y . | Immunologic subtype . | Genetic translocation . |
|---|---|---|---|---|
| 1 | F | 7 | Early-pre | 9;22/4;11 neg* |
| 2 | F | 6 | Early-pre | 9;22/4;11 neg |
| 3 | F | 5 | Early-pre | 9;22/4;11 neg |
| 4 | F | 4 | Early-pre | 9;22/4;11 neg |
| 5 | M | 3 | Early-pre | 9;22/4;11 neg |
| 6 | M | 2 | Early-pre | 9;22/4;11 neg |
| 7 | F | 8 | Early-pre | 12;21 |
| 8 | F | 7 | Early-pre | 12;21 |
| 9 | M | 6 | Early-pre | 12;21 |
| 10 | M | 5 | Early-pre | Neg† |
| 11 | M | 3 | Early-pre | 12;21 |
| 12 | M | 2 | Early-pre | 9;22 and 1;19 |
| 13 | M | 6 | Early-pre | 12;21 |
| 14 | M | 2 | Early-pre | Neg |
| 15 | M | 8 | Early-pre | Neg |
| 16 | M | 5 | Early-pre | Neg |
| 17 | M | 4 | Early-pre | Neg |
| 18 | M | 12 | Early-pre | Neg |
| 19 | F | 6 | Early-pre | Neg |
| 20 | M | 6 | Pre-B | 12;21 |
| 21 | M | 3 | Pre-B | Neg |
| 22 | M | 2 | Pre-B | Down syndrome |
| 23 | F | 8 | Pre-B | 1;19 |
| 24 | F | 8 | Pre-B | Neg |
| 25 | M | 6 | Pre-B | Neg |
| 26 | F | < 1 (infant) | Pro-B | 4;11 |
| 27 | F | 3 | Pro-B | Neg |
| 28 | F | 5 | Pro-B | Neg |
| 29 | M | 4 | Pro-B | 4;11 |
All data are as of diagnosis. The following genetic translocations have been tested: 9;22, 4;11, 12;21, and 1;19.
9;22/4;11 neg indicates these patients did not show 9;22 or 4;11 translocations. Other translocations have not been tested.
Neg indicates negative. These patients did not show any genetic translocation.